Mcp- Sf (Metoclopramide Hydrochloride)

Metoclopramide Hydrochloride is used to manage conditions involving nausea, vomiting and delayed gastric emptying.

• Nausea and vomiting: reduces the frequency and severity of episodes caused by chemotherapy, surgery or other triggers.
• Gastroparesis: enhances gastric motility to improve stomach emptying in patients with delayed gastric transit.
• Migraine‑associated nausea: alleviates nausea that accompanies acute migraine attacks.

• Metoclopramide Hydrochloride antagonizes dopamine D2 receptors in the chemoreceptor trigger zone and throughout the gastrointestinal tract. By blocking dopamine, it increases acetylcholine release, which stimulates smooth‑muscle contraction, enhancing gastric emptying and intestinal transit. The central D2 blockade also diminishes the vomiting reflex, providing antiemetic activity.

Metoclopramide Hydrochloride may cause a range of adverse reactions, from mild to serious.

Common Side Effects

• Drowsiness
• Fatigue
• Restlessness or akathisia
• Diarrhea
• Headache
• Dry mouth

Serious or Rare Side Effects

• Extrapyramidal symptoms (e.g., dystonia, parkinsonism)
• Tardive dyskinesia with prolonged use
• Neuroleptic malignant syndrome
• Severe allergic reactions (anaphylaxis, skin rash)
• Hyperprolactinemia leading to hormonal disturbances
• Depression or suicidal thoughts

Before prescribing Metoclopramide Hydrochloride, clinicians should consider several safety aspects.

• Assess for movement disorders: monitor patients for extrapyramidal symptoms, especially during the first days of therapy.
• Review cardiac history: avoid in patients with known QT‑interval prolongation or significant arrhythmias.
• Consider renal function: dose adjustment may be required in severe renal impairment.
• Avoid in known hypersensitivity: discontinue immediately if an allergic reaction occurs.
• Pregnancy and lactation: use only when the potential benefit justifies the potential risk to the fetus or infant.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Metoclopramide Hydrochloride can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid)

• Antipsychotics (e.g., haloperidol): increased risk of severe extrapyramidal reactions.
• CNS depressants (e.g., benzodiazepines, barbiturates): additive sedation and respiratory depression.
• CYP2D6 inhibitors (e.g., quinidine, fluoxetine): may raise metoclopramide plasma concentrations.

Moderate Interactions (Monitor Closely)

• Opioids (e.g., morphine, codeine): heightened nausea and potential for reduced analgesic effect.
• Selective serotonin reuptake inhibitors (e.g., sertraline, citalopram): possible serotonin syndrome when combined.
• Alcohol: enhanced central nervous system depression and dizziness.